Hier finden Sie eine Übersicht unserer aktuellen Veröffentlichungen.

  • Rößler M , Jacob J, Risch L, Tesch F, Enders D, Wende D,  Jucknewitz  R, Weidinger O,  Batram M,  Ballesteros P, Baßler S, Hertle D,  Repschläger U, Richter N, Schulte C, Schramm A, Sobik F, Treskova-Schwarzbach M, Scholz S,  Schmitt J, Walker J: Hierarchisierung von Risikofaktoren für schwere COVID-19-Erkrankungsverläufe im Kontext der COVID-19-Schutzimpfungen. Eine gepoolte GKV-Routinedatenanalyse basierend auf 30 Mio. Versicherten. Epidemiologisches Bulletin 19/2021, 2021. doi: 10.25646/8405.
  • Jacob J, Klamroth R, Ploner T, Harder T, Koch J, Wichmann O, Walker J: Incidence of cerebral venous sinus thrombosis in adults in Germany – a  retrospective study using health claims data. Preprint, April 2021.
  • Sierocinski E, Angelow A, Mainz A, Walker J, Chenot J-F: Patientensicherheit in der Rheumatherapie – Labormonitoring bei Methotrexat. Zeitschrift für Rheumatologie, 2021. doi: 10.1007/s00393-021-00976-7.
  • Bossert J, Ludwig M, Wronski P, Koetsenruijter J, Krug K, Villalobos M, Jacob J, Walker J, Thomas M, Wensing M: Lung cancer patients’ comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study. npj primary care respiratory medicine, 2021. doi: https://doi.org/10.1038/s41533-020-00214-8.
  • Ludwig M, Jacob J, Basedow F, Andersohn F, Walker J: Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany. Int J Infect Dis, 2020. doi: 10.1016/j.ijid.2020.11.204
  • Beckmann A, Bitzer E-M, Lederle M, Ihle P, Walker J, Marshall U, Horenkamp-Sonntag D, Schneider S,  Zeymer U for the REVASK study group: Health Care Analysis on Myocardial Revascularization in Patients with Chronic Coronary Artery Disease: The Multicenter REVASK Study: Design and Protocol. Thorac Cardiovasc Surg, 2020. doi: 10.1055/s-0040-1721391 
  • Schmedt N, Enders D, Walker J, Garbe E, Douros A: Sodium-glucose co-transporter 2 inhibitors and the risk of venous thromboembolism in patients with type 2 diabetes: a cohort study. Am J Med, 2020. doi10.1016/j.amjmed.2020.10.046
  • Beermann S, Jacob J, Dudareva S, Jansen K, Marcus U, Zimmermann R, Bremer V: Gelingt das Screening von Schwangeren auf HIV, Syphilis und Hepatitis B in Deutschland? Eine Analyse auf Basis von Routinedaten. Bundesgesundheitsblatt 631143–1150 (2020). doi: 10.1007/s00103-020-03199-4
  • Ohlmeier C, Gothe H, Haas J, Osowski U, Weinhold C, Blauwitz S, Schmedt N, Galetzka W, Berkemeier F, Tackenberg B, Stangel M: Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data. PLoS One, 2020, doi: 10.1371/journal.pone.0231846
  • Angelow A, Ploner T, Grimmsmann T, Walker J, Chenot J-F: Dual renin-angiotensin-aldosterone blockade: Implementation of published research and Dear Doctor letters in ambulatory care: A retrospective observational study using prescription data. Pharmacoepidemiol Drug Saf., 2020, doi: 10.1002/pds.4965
  • Jacob J, Schmedt N, Hickstein L, Galetzka W, Walker J, Enders D: Comparison of Approaches to Select a Propensity Score Matched Control Group in the Absence of an Obvious Start of Follow Up for this Group: An Example Study on the Economic Impact of the DMP Bronchial Asthma. Gesundheitswesen, 2019, doi: 10.1055/a-0948-5356
  • Viniol A, Ploner T, Hickstein L, Haasenritter J, Klein K M, Walker J, Donner-Banzhoff N, Becker A: Prescribing practice of pregabalin/ gabapentin in pain therapy: an evaluation of German claim data. BMJ Open, 2019, doi: 10.1136/bmjopen-2018-021535
  • Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, Hindricks G, Bollmann A: Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany -An analysis of over 5 million patients. PLoS One, 2018, doi: 10.1371/journal.pone.0196612
  • Beier D, Galetzka W, Hickstein L, Meinhardt M, Häckl D, Schmedt N: Epidemiology, outcomes and treatment patterns among patients with coronary artery disease and/or peripheral artery disease treated in routine clinical practice in Germany. 25. Jahrestagung der GAA, 2018, doi: 10.3205/18gaa03
  • Galetzka W, Jacob J, Enders D: Adpation eines Modells aus dem Natural Language Processing zur Prognose von Leistungskosten auf Basis von GKV Routinedaten. 17. Deutscher Kongress für Versorgungsforschung, 2018.
  • Galetzka W, Jacob J, Enders D: Adaption eines Modells aus dem Natural Language Processing zur Prognose von Psychiatrieeinweisungen auf Basis von GKV Routinedaten. 63. Jahrestagung der GMDS, 2018.
  • Ploner T, Heß S, Walker J, Grum M, Drewe-Boss P: Disease Trajectory Analysis of COPS patients based on Health claims data. Herbstworkshop DG Epi, 2018.
  • Jacob J, Walker J: Kosten- und Mengeneffekte des MICADO- Selektivvertrags. Monitor Versorgungsforschung, 2018, doi: 10.24945/MVF.04.18.1866-0533.2092.
  • Schmedt NAndersohn F, Walker J, Garbe E: Sodium-glucose co-transporter-2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case-control study. Diabetes Obes Metab, 2018, doi: 10.1111/dom .13480. Abstract.
  • Hickstein L, Kiel S, Raus C, Heß S, Walker J, Chenot J.F.: Akupunktur als Leistung der gesetzlichen Krankenversicherung in Deutschland – eine retrospektive Beobachtungsstudie basierend auf Abrechnungsdaten. Der Schmerz, 2018, doi: 10.1007/s00482-017-0258-2. Abstract.
  • Jacob J, Mischker A, Klinger N, Zickermann C, Walker J: Evaluation eines Infektionsscreenings auf bakterielle Vaginosen zur Vermeidung von Frühgeburten. Monitor Versorgungsforschung, 05/2017, S. 41-45, doi: 10.24945/MVF.05.17.1866-0533.2039. Abstract.
  • Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe K, Ringshausen F: Burden of non-tuberculous mycobacterial pulmonary disease in Germany. European Respiratory Journal, 2017, doi: 10.1183/13993003.02109-2016. Abstract.
  • Walker J, Mertens U.K, Schmidt C.O, Chenot J.-F: Effect on healthcare utilization and costs of spinal manual therapy for acute low back pain in routine care: A propensity score matched cohort study. PLOS ONE, 2017, doi:https://doi.org/10.1371/journal.pone.0177255. Abstract.
  • Andersohn F, Walker J : Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiology and Drug Safety, 2016 , doi: 10.1002/pds.3895. Abstract.
  • Jacob J, Lehne M, Mischker A, Klinger N, Zickermann C, Walker J : Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth, The European Journal of Health Economics, 2016, doi: 10.1007/s10198-016-0850-x, Abstract
  • Andersohn F, Walker J: Faktencheck Rücken Ausmaß und regionale Variationen von Behandlungsfällen und bildgebender Diagnostik, Bertelsmann Stiftung, 2016
  • Bode K, Vogel R, Walker J, Kröger C: Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data, The European Journal of Health Economics, 2016, doi: 10.1007/s10198-016-0858-2, Abstract.
  • Viniol A, Hickstein L, Walker J, Donner-Banzhoff N, Baum E, Becker A: Influence of thyroid hormone therapy on the fracture rate – a claims data cohort study. Bone, 2016, doi: 10.1016/j.bone.2016.03.002, Abstract.
  • Jacob J, Sunder-Plassmann D, Walker J: Evaluation eines Integrierten Versorgungsvertrages zur Versorgung von Patienten mit chronischer Herzinsuffizienz, Monitor Versorgungsforschung, 2016. Abstract.